With its stock down 7.1% over the past month, it is easy to disregard Gerresheimer (ETR:GXI). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with ...

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to ...

Feb 26 (Reuters) - German packaging and medical equipment maker Gerresheimer (GXIG.DE), opens new tab, which makes pens used to inject weight loss drugs such as Novo Nordisk's (NOVOb.CO), opens ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a price ...

Thank you for joining us this morning. For those who are new to the call, my name is Dietmar Siemssen, and I'm the CEO of Gerresheimer. I will start by giving you an overview of our business ...

Prior to this announcement, Gerresheimer's earnings easily covered the dividend, but free cash flows were negative. With the company not bringing in any cash, paying out to shareholders is bound ...

DUESSELDORF, GERMANY / ACCESS Newswire / February 26, 2025 / Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries ...

Deutsche Bank analyst Falko Friedrichs maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of ...

The potential acquisition comes as Gerresheimer AG, known for producing pens for injectable weight loss drugs like Wegovy, has been in preliminary talks with private equity investors regarding a sale.

Exclusive: KKR-Warburg Pincus group submit non-binding bid for Gerresheimer, sources say A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which ...

FRANKFURT/NEW YORK (Reuters) -A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to inject weight loss drugs like Wegovy ...